Beranda7CA • FRA
add
Camurus AB
Tutup sebelumnya
€53,10
Rentang hari
€48,86 - €50,35
Rentang tahun
€45,66 - €62,60
Kapitalisasi pasar
31,79 M SEK
Volume Rata-Rata
16,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
StockWatch.id
1 jam yang lalu
Wall Street Makin Ngebut! S&P 500 Cuan 5% Meski Sentimen Konsumen Anjlok
0,70%
0,78%
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 558,34 jt | 43,17% |
Biaya operasional | 280,17 jt | -0,10% |
Laba bersih | 197,25 jt | 153,33% |
Margin laba bersih | 35,33 | 76,92% |
Penghasilan per saham | 3,29 | 149,24% |
EBITDA | 239,55 jt | 190,91% |
Tarif pajak efektif | 22,33% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,88 M | 26,57% |
Total aset | 3,97 M | 29,68% |
Total liabilitas | 482,15 jt | 16,16% |
Total ekuitas | 3,49 M | — |
Saham yang beredar | 58,88 jt | — |
Harga terhadap nilai buku | 0,90 | — |
Tingkat pengembalian aset | 15,46% | — |
Tingkat pengembalian modal | 17,31% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 197,25 jt | 153,33% |
Kas dari operasi | 77,64 jt | 113,70% |
Kas dari investasi | -34,14 jt | -1.992,16% |
Kas dari pembiayaan | -6,10 jt | -100,58% |
Perubahan kas bersih | 25,36 jt | -97,66% |
Arus kas bebas | -47,50 jt | -6.656,70% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
265
